Inhaled Form of Anthrax More Deadly Than Skin Infection
Posted on: Saturday, 2 August 2008, 13:46 CDT
Americans became fearful of anthrax in October of 2001, after the white powder killed five people and sickened 17 as it was sent in envelopes through the U.S. postal service. The deadly attacks created contamination scares throughout the country and forced the post office to alter its letter-handling procedures.
The tragedy is now back in the news with the apparent suicide of biodefense researcher Bruce E. Ivins of the government labs at Fort Detrick, Maryland. At the time of his death, prosecutors had been preparing to seek charges against Ivins for the 2001 attacks.
The spores that cause anthrax, Bacillus anthracis, commonly occur in soil. At one time, the skin form of the anthrax infection was fairly widespread, especially among livestock and those who work with the animals, and effectively treated with antibiotics.
However, the mailed anthrax proved deadly as the spores were inhaled when the poisoned mail was opened. These spores then settled in the lungs of those exposed, causing an infection that is difficult to diagnose and nearly impossible to cure once symptoms appear. The infection is not contagious.
Experts initially estimated that 8,000 to 10,000 spores in the lungs can cause the inhaled form of an anthrax infection, but later questioned the figure. Infection with the skin form of the disease can result from significantly fewer spores.
In the aftermath of the attacks, there were media reports that the contaminated letters contained additives and had also been subjected to sophisticated milling, techniques used to weaponize the anthrax spores to make them more deadly. However, officials with the FBI later said these reports were inaccurate.
The skin form of an anthrax infection typically begins three to five days after exposure, with the appearance of a small, painless blister that is red around the edges. A day or two later, the blister turns black before eventually drying up and leaving a black scab behind. The scab usually falls off within a week or two. Anthrax skin infections are treated with common antibiotics such as Cipro, penicillin or doxycycline, which are very effective.
Experts say that left untreated, approximately 5 percent of anthrax skin infections will progress to a deadly bloodstream infection that is almost always fatal.
Additional information about anthrax can be viewed at the U.S. Centers for Disease Control and Prevention Web site at http://emergency.cdc.gov/agent/anthrax/needtoknow.asp.
Source: redOrbit Staff & Wire Reports
Related Articles
- Elusys' Anthim(TM) Dramatically Improves Survival of Animals Treated After Active Anthrax Infection
- Infections Linked to Heart Attack
- Anthrax Monoclonal Antibody Valortim(TM) Demonstrates Therapeutic Effect in New Primate Model of Established Anthrax Infection
- FDA Grants Fast Track Designation to Emergent BioSolutions' BioThrax(R) for Post-Exposure Prophylaxis Against Anthrax Infection
- PharmAthene and Medarex Receive Orphan Drug Designation for Valortim(TM) to Treat Anthrax Infection
- PharmAthene and Medarex Receive FDA Fast Track Designation for Valortim(TM) for Treatment of Anthrax Infection
- Covalent Group, Inc. And Emergent BioSolutions Sign Contract to Develop Immune Globulins for Treatment Exposure of Anthrax Infection
- Hundreds of U.S. Troops in Iraq Infected With Potentially Deadly Drug Resistant Bacteria According to Forbes.Com
- Critical Step Traced in Anthrax Infection
- Human Genome Sciences Publishes Results of Phase 1 Clinical Trial of ABthrax(TM) for Use in Prevention and Treatment of Anthrax Infection
User Comments (0)


RSS Feeds